tiprankstipranks
Advertisement
Advertisement
Celldex reports barzolvolimab study did not meet primary, secondary endpoints
PremiumThe FlyCelldex reports barzolvolimab study did not meet primary, secondary endpoints
2d ago
Celldex price target raised to $100 from $90 at Guggenheim
Premium
The Fly
Celldex price target raised to $100 from $90 at Guggenheim
3d ago
Celldex CFO Sam Martin to retire in 2027
Premium
The Fly
Celldex CFO Sam Martin to retire in 2027
8d ago
Celldex price target raised to $45 from $38 at UBS
PremiumThe FlyCelldex price target raised to $45 from $38 at UBS
1M ago
Celldex price target raised to $54 from $38 at Wells Fargo
Premium
The Fly
Celldex price target raised to $54 from $38 at Wells Fargo
2M ago
Celldex price target raised to $38 from $34 at Goldman Sachs
Premium
The Fly
Celldex price target raised to $38 from $34 at Goldman Sachs
3M ago
Morning News Wrap-Up, 4/20/26: Today’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up, 4/20/26: Today’s Biggest Stock Market Stories!
3M ago
A Top Wall Street Analyst ‘Can’t Ignore’ Celldex Stock (CLDX)
Premium
Market News
A Top Wall Street Analyst ‘Can’t Ignore’ Celldex Stock (CLDX)
3M ago
Celldex upgraded to Overweight from Underweight at Barclays
Premium
The Fly
Celldex upgraded to Overweight from Underweight at Barclays
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100